
Active surveillance remains a viable option for low-risk, localized prostate cancer, according to two studies presented during the Annual Scientific Meeting of the American Urological Association (AUA), yet researchers point out a strong need for regular monitoring and development of stronger clinical predictors of progression.
Click here for full Story http://www.medicalnewstoday.com/articles/107743.php |